These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 1913705)

  • 1. Pharmacological alleviation of combined cholinergic/noradrenergic lesion-induced memory deficits in rats.
    Santucci AC; Haroutunian V; Davis KL
    Clin Neuropharmacol; 1991; 14 Suppl 1():S1-8. PubMed ID: 1913705
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Restoration of cholinomimetic activity by clonidine in cholinergic plus noradrenergic lesioned rats.
    Haroutunian V; Kanof PD; Tsuboyama G; Davis KL
    Brain Res; 1990 Jan; 507(2):261-6. PubMed ID: 2110845
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological alleviation of cholinergic lesion induced memory deficits in rats.
    Haroutunian V; Kanof P; Davis KL
    Life Sci; 1985 Sep; 37(10):945-52. PubMed ID: 4040999
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of cholinergic drugs on learning impairment in ventral globus pallidus-lesioned rats.
    Ueki A; Miyoshi K
    J Neurol Sci; 1989 Mar; 90(1):1-21. PubMed ID: 2723670
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Excitotoxic lesions of basal forebrain cholinergic neurons: effects on learning, memory and attention.
    Muir JL; Page KJ; Sirinathsinghji DJ; Robbins TW; Everitt BJ
    Behav Brain Res; 1993 Nov; 57(2):123-31. PubMed ID: 7509608
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Frontal cortex as the site of action of physostigmine in nbM-lesioned rats.
    Haroutunian V; Mantin R; Kanof PD
    Physiol Behav; 1990 Jan; 47(1):203-6. PubMed ID: 2326337
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of THA on passive avoidance retention performance of intact, nucleus basalis, frontal cortex and nucleus basalis + frontal cortex-lesioned rats.
    Riekkinen P; Sirviö J; Riekkinen M; Riekkinen P
    Pharmacol Biochem Behav; 1991 Aug; 39(4):841-6. PubMed ID: 1763101
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of continuous infusion of cholinergic drugs on memory impairment in rats with basal forebrain lesions.
    Miyamoto M; Narumi S; Nagaoka A; Coyle JT
    J Pharmacol Exp Ther; 1989 Feb; 248(2):825-35. PubMed ID: 2918482
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NS-3, a TRH-analog, reverses memory disruption by stimulating cholinergic and noradrenergic systems.
    Ogasawara T; Itoh Y; Tamura M; Ukai Y; Yoshikuni Y; Kimura K
    Pharmacol Biochem Behav; 1996 Feb; 53(2):391-9. PubMed ID: 8808149
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of physostigmine on memory consolidation and retrieval processes in intact and nucleus basalis-lesioned rats.
    Santucci AC; Kanof PD; Haroutunian V
    Psychopharmacology (Berl); 1989; 99(1):70-4. PubMed ID: 2506606
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interactions of forebrain cholinergic and somatostatinergic systems in the rat.
    Haroutunian V; Kanof PD; Davis KL
    Brain Res; 1989 Sep; 496(1-2):98-104. PubMed ID: 2804656
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reversal of learning and memory impairments following lesion of the nucleus basalis magnocellularis (NBM) by concurrent noradrenergic depletion using DSP4 in the rat.
    Moran PM; LeMaître MH; Philouze V; Reymann JM; Allain H; Leonard BE
    Brain Res; 1992 Nov; 595(2):327-33. PubMed ID: 1281740
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Continuous physostigmine infusion in rats with excitotoxic lesions of the nucleus basalis magnocellularis: effects on performance in the water maze task and cortical cholinergic markers.
    Mandel RJ; Chen AD; Connor DJ; Thal LJ
    J Pharmacol Exp Ther; 1989 Nov; 251(2):612-9. PubMed ID: 2810114
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective memory loss following nucleus basalis lesions: long term behavioral recovery despite persistent cholinergic deficiencies.
    Bartus RT; Flicker C; Dean RL; Pontecorvo M; Figueiredo JC; Fisher SK
    Pharmacol Biochem Behav; 1985 Jul; 23(1):125-35. PubMed ID: 4041042
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cholinergic drugs reverse AF64A-induced impairment of passive avoidance learning in rats.
    Yamazaki N; Kato K; Kurihara E; Nagaoka A
    Psychopharmacology (Berl); 1991; 103(2):215-22. PubMed ID: 2027921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loss of nucleus basalis magnocellularis, but not septal, cholinergic neurons correlates with passive avoidance impairment in rats treated with 192-saporin.
    Zhang ZJ; Berbos TG; Wrenn CC; Wiley RG
    Neurosci Lett; 1996 Jan; 203(3):214-8. PubMed ID: 8742031
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cholinergic ventral forebrain grafts into the neocortex improve passive avoidance memory in a rat model of Alzheimer disease.
    Fine A; Dunnett SB; Björklund A; Iversen SD
    Proc Natl Acad Sci U S A; 1985 Aug; 82(15):5227-30. PubMed ID: 3860857
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tetrahydroaminoacridine improves the spatial acquisition deficit produced by nucleus basalis lesions in rats.
    Kwo-On-Yuen PF; Mandel R; Chen AD; Thal LJ
    Exp Neurol; 1990 Jun; 108(3):221-8. PubMed ID: 2351210
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cholinergic drugs regulate passive avoidance performance via the amygdala.
    Riekkinen P; Riekkinen M; Sirviö J
    J Pharmacol Exp Ther; 1993 Dec; 267(3):1484-92. PubMed ID: 8263810
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pilocarpine and physostigmine attenuate spatial memory impairments produced by lesions of the nucleus basalis magnocellularis.
    Murray CL; Fibiger HC
    Behav Neurosci; 1986 Feb; 100(1):23-32. PubMed ID: 3954876
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.